VRCA
Verrica Pharmaceuticals (VRCA)
$91
About Verrica Pharmaceuticals (VRCA)
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Details
Daily high
$7.07
Daily low
$6.70
Price at open
$6.70
52 Week High
$9.82
52 Week Low
$3.28
Market cap
105.7M
Dividend yield
0.00%
Volume
124,245
Avg. volume
157,235
P/E ratio
-1.92
Verrica Pharmaceuticals News
Details
Daily high
$7.07
Daily low
$6.70
Price at open
$6.70
52 Week High
$9.82
52 Week Low
$3.28
Market cap
105.7M
Dividend yield
0.00%
Volume
124,245
Avg. volume
157,235
P/E ratio
-1.92